Comparison of a SegNet-based Algorithm Estimating Epifascial Fibrosis
Sponsor
Chungnam National University Sejong Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04811677
Collaborator
(none)
27
1
14.9
1.8
Study Details
Study Description
Brief Summary
To approval for detecting lymphedema fibrosis before its progression, verification of CT-based quantification of suprafascial microscopic fibrosis has been tried.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
27 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Comparison of a SegNet-based Algorithm Quantitatively Estimating Epifascial Fibrosis in Three-dimensional Computed Tomography Images to the Clinical Lymphedema Grading Method
Actual Study Start Date
:
Jan 1, 2018
Actual Primary Completion Date
:
Mar 30, 2019
Actual Study Completion Date
:
Mar 30, 2019
Outcome Measures
Primary Outcome Measures
- accuracy [within 1 week after CT scanning]
a ratio between the correctly classified pixel and all the classified pixel in one label.
Secondary Outcome Measures
- First index [within 1 week after CT scanning]
(P_(Fat in Affected)+P_(Fibrosis in Affected))/(P_(Fat in Unaffected)+P_(Fibrosis in Unaffected) ) " "
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
- The patients who were clinically diagnosed with unilateral limb lymphedema and who underwent multi-frequency bio-electric impedance (BEI) analysis and CT scanning.
Exclusion Criteria:
- The patients who were diagnosed with deep vein thrombosis, bilateral limbs involvement, vascular diseases or local infection were excluded.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Chungnam National University Sejong Hospital | Sejong | Korea, Republic of | 30099 |
Sponsors and Collaborators
- Chungnam National University Sejong Hospital
Investigators
- Principal Investigator: Chang Ho Hwang, Chungnam National University Sejong Hospital
Study Documents (Full-Text)
More Information
Publications
None provided.Responsible Party:
Chang Ho Hwang, MD, PhD.,
Chief director,
Chungnam National University Sejong Hospital
ClinicalTrials.gov Identifier:
NCT04811677
Other Study ID Numbers:
- UUH 2018-04-009
First Posted:
Mar 23, 2021
Last Update Posted:
Mar 23, 2021
Last Verified:
Mar 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: